First Trust Advisors
AMRI

First Trust Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

First Trust Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,937
Closed -$237K – 2536
2017
Q2 		$237K Buy
+10,937
New +$199K ﹤0.01% 2251
2016
Q4 		– Sell
-39,907
Closed -$659K – 2562
2016
Q3 		$659K Buy
+39,907
New +$591K ﹤0.01% 1898
2016
Q2 		– Sell
-86,368
Closed -$1.32M – 2447
2016
Q1 		$1.32M Buy
86,368
+47,323
+121% +$742K ﹤0.01% 1534
2015
Q4 		$775K Sell
39,045
-99,169
-72% -$1.88M ﹤0.01% 1830
2015
Q3 		$2.41M Buy
+138,214
New +$2.81M 0.01% 1300
2015
Q1 		– Sell
-95,550
Closed -$1.56M – 2347
2014
Q4 		$1.56M Sell
95,550
-7,062
-7% -$130K 0.01% 1569
2014
Q3 		$2.27M Buy
102,612
+90,950
+780% +$1.86M 0.01% 1310
2014
Q2 		$235K Sell
11,662
-4,525
-28% -$76.6K ﹤0.01% 2110
2014
Q1 		$301K Buy
16,187
+234
+1% +$3.22K ﹤0.01% 2083
2013
Q4 		$161K Sell
15,953
-9,949
-38% -$120K ﹤0.01% 2171
2013
Q3 		$334K Sell
25,902
-17,043
-40% -$210K ﹤0.01% 2070
2013
Q2 		$510K Buy
+42,945
New +$465K ﹤0.01% 1793

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

First Trust Advisors's AMRI Position: Q3 2017 in Review

First Trust Advisors sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 10,937 shares — an estimated $237K sold.

First Trust Advisors first reported a position in AMRI in Q2 2013 and held it in 12 quarters. The position peaked at $2.41M in Q3 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • First Trust Advisors reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • First Trust Advisors sold 10,937 Albany Molecular Research Inc shares in Q3 2017, an estimated $237K.
  • First Trust Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 12 quarters.
  • First Trust Advisors's Albany Molecular Research Inc position peaked at $2.41M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on First Trust Advisors's 13F filing for Q3 2017, filed 24 Oct 2017.